Opendata, web and dolomites

B2B SIGNED

Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 B2B project word cloud

Explore the words cloud of the B2B project. It provides you a very rough idea of what is the project "B2B" about.

drugs    clinically    hurdle    vascular    ossicles    ossicle    assembled    incurable    capillary    spontaneous    pursue    device    lack    nor    branched    comprising    suppressing    site    hierarchically    networks    dissect    bioprinted    limitations    longitudinally    found    drug    cell    fold    vitro    mortality    spread    circuit    date    passing    size    generate    tissue    throughput    recapitulate    cancer    metastasis    tree    therapies    context    containing    circulating    physiological    repurposing    macro    overcome    continuum    complexity    transcend    hits    3d    patient    dynamics    empower    connected    million    model    technologies    bone    hierarchical    endothelial    composition    patients    metastatic    micro    organoids    vascularized    propagate    identification    agents    b2b    dimensions    disease    closed    linked    screening    consequently    cells    breakthrough    single    first    spanning    tumor    structure    ones    newly    self    woman    barrier    marrow    breast    hybrid   

Project "B2B" data sheet

The following table provides information about the project.

Coordinator
CONSIGLIO NAZIONALE DELLE RICERCHE 

Organization address
address: PIAZZALE ALDO MORO 7
city: ROMA
postcode: 185
website: www.cnr.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.b2bproject.eu
 Total cost 3˙799˙371 €
 EC max contribution 3˙799˙371 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-1-2016-2017
 Funding Scheme RIA
 Starting year 2018
 Duration (year-month-day) from 2018-07-01   to  2022-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) coordinator 711˙887.00
2    UNIVERSITAT BASEL CH (BASEL) participant 1˙198˙345.00
3    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 464˙383.00
4    REACT4LIFE SRL IT (GENOVA) participant 406˙600.00
5    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL (ROTTERDAM) participant 390˙825.00
6    CAMBRIDGE INNOVATION TECHNOLOGIES CONSULTING LIMITED UK (CAMBRIDGE) participant 234˙242.00
7    IN SRL IT (UDINE) participant 230˙587.00
8    BIOEMISSION TECHNOLOGY SOLUTIONS IKE EL (ATHINA) participant 162˙500.00

Map

 Project objective

Cancer patients developing a metastatic disease are considered incurable. Breast cancer hits 1 woman in 8, and its most common metastatic site is the bone. A major hurdle to overcome breast cancer mortality is the lack of understanding of dynamics leading to the spread of breast cancer cells to the bone. Consequently, metastasis-suppressing agents have not been found to date, neither as newly developed drugs nor as repurposing of existing ones. The aim of the B2B device is to generate a first-of-a-kind 3D model of spontaneous breast cancer metastasis to the bone to dissect the complexity of the metastatic process and empower high-throughput drug screening in a physiological context. B2B will pursue its goal of developing a novel hybrid device able to 1) propagate patient-derived tumor organoids of clinically-relevant dimensions, with their own self-assembled micro-capillary networks, which are 2) continuously linked to a 3D bioprinted macro-vascular tree, organized in a hierarchical branched structure, connected in a closed circuit with 3) a vascularized marrow-containing bone ossicle, as the metastatic target. This is a unique approach, spanning the micro (single circulating metastatic cells, passing the endothelial barrier of capillary networks) to macro (tumor organoids and ossicles of clinically relevant size and tissue composition, connected by a hierarchically organized vascular tree) continuum to recapitulate spontaneous bone metastasis formation in breast cancer. This technology will transcend the limitations of current in vitro technologies, enabling physiological tissue-level complexity with organoids comprising several million cells, and its expected impact will be three-fold: to recapitulate the spontaneous metastatic process in breast cancer, to provide a breakthrough technology to investigate metastasis longitudinally and at the single cell level, and to lead to the identification of metastasis-suppressing therapies for breast cancer patients.

 Deliverables

List of deliverables.
Website and logo Websites, patent fillings, videos etc. 2019-10-08 17:12:39

Take a look to the deliverables list in detail:  detailed list of B2B deliverables.

 Publications

year authors and title journal last update
List of publications.
2018 Francesc Castro-Giner, Sofia Gkountela, Cinzia Donato, Ilaria Alborelli, Luca Quagliata, Charlotte Ng, Salvatore Piscuoglio, Nicola Aceto
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations
published pages: 31, ISSN: 2075-4418, DOI: 10.3390/diagnostics8020031
Diagnostics 8/2 2019-08-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "B2B" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "B2B" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

NanoBRIGHT (2019)

BRInGing nano-pHoTonics into the brain

Read More  

NeuroStimSpinal (2019)

A STEP FORWARD TO SPINAL CORD INJURY REPAIR USING INNOVATIVE STIMULATED NANOENGINEERED SCAFFOLDS

Read More  

ATEMPGRAD (2019)

Analysing Temperature Effects with a Mobile and Precise Gradient Device

Read More